Development of therapeutics based on the Feldan Shuttle, a peptide-based delivery platform11-50 Employees
- B2B
- Growth StageExpanding market presence
- Recently fundedRaised funding in the past six months
- Website
- Location
- Company size
- 11-50 people
- Total raised
- $6M
- Company type
- Biotech
- Markets
People at Feldan Therapeutics
Francois-Thomas Michaud
Vincent Menard
Director Of Strategy at Feldan Therapeutics
Hooshmand Sheshbaradaran
A
Partner Novateur Ventures; CEO Niiki Pharma; Global Director BD, Roche; Global Director Marketing, Pharmacia/Pfizer; PhD Karolinska Institute, Stockholm.
Ali Ardakani
A
Biotech Investor. 25yrs operating experience in therapeutics deals; startup Chief Business Officer; First $ into NewCos; Yale, Princeton PhD, MITSloan MBA NOTE: This Syndicate is not super active anymore. I run a seperate VC fund.